Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy.
Su ZhangYang MengLian ZhouLei QiuHeping WangDan SuBo ZhangKui-Ming ChanJunhong HanPublished in: MedComm (2022)
Emerging evidence indicates that resolution of inflammation is a critical and dynamic endogenous process for host tissues defending against external invasive pathogens or internal tissue injury. It has long been known that autoimmune diseases and chronic inflammatory disorders are characterized by dysregulated immune responses, leading to excessive and uncontrol tissue inflammation. The dysregulation of epigenetic alterations including DNA methylation, posttranslational modifications to histone proteins, and noncoding RNA expression has been implicated in a host of inflammatory disorders and the immune system. The inflammatory response is considered as a critical trigger of epigenetic alterations that in turn intercede inflammatory actions. Thus, understanding the molecular mechanism that dictates the outcome of targeting epigenetic regulators for inflammatory disease is required for inflammation resolution. In this article, we elucidate the critical role of the nuclear factor-κB signaling pathway, JAK/STAT signaling pathway, and the NLRP3 inflammasome in chronic inflammatory diseases. And we formulate the relationship between inflammation, coronavirus disease 2019, and human cancers. Additionally, we review the mechanism of epigenetic modifications involved in inflammation and innate immune cells. All that matters is that we propose and discuss the rejuvenation potential of interventions that target epigenetic regulators and regulatory mechanisms for chronic inflammation-associated diseases to improve therapeutic outcomes.
Keyphrases
- oxidative stress
- dna methylation
- gene expression
- immune response
- signaling pathway
- inflammatory response
- coronavirus disease
- nlrp inflammasome
- nuclear factor
- induced apoptosis
- transcription factor
- toll like receptor
- endothelial cells
- type diabetes
- randomized controlled trial
- physical activity
- stem cells
- multidrug resistant
- metabolic syndrome
- insulin resistance
- skeletal muscle
- copy number
- weight loss
- drug induced
- bone marrow
- gram negative
- binding protein
- antimicrobial resistance
- weight gain